Early caplacizumab and obinutuzumab enable successful treatment of relapsing thrombotic thrombocytopenic purpura without therapeutic plasma exchange: a case report. [PDF]
Front ImmunolSchimpf J, Haller P, Zitt E.
europepmc +1 more source
Exploring Hypercoagulability in Post-COVID Syndrome (PCS): An Attempt at Unraveling the Endothelial Dysfunction. [PDF]
J Clin MedMuys M +4 more
europepmc +1 more source
Fatal interplay between acquired thrombotic thrombocytopenic purpura and posterior reversible encephalopathy syndrome: a case report. [PDF]
Radiol Case RepKakde P +5 more
europepmc +1 more source
Hereditary thrombotic thrombocytopenic purpura mimicking immune thrombocytopenia was revealed by miscarriage-novel compound heterozygous mutations in hTTP. [PDF]
BMC Med GenomicsZhou R +6 more
europepmc +1 more source
Hemolytic uremic syndrome with Mycoplasma pneumoniae infection and membrane cofactor protein mutation [PDF]
, 2016 Csuka, Dorottya +5 more
core
A compound heterozygous ADAMTS13 mutation causes congenital thrombotic thrombocytopenic purpura: a case report. [PDF]
Front Med (Lausanne)Huang Y +6 more
europepmc +1 more source
ADAMTS13 Improves Hepatic Platelet Accumulation in Pyrrolizidine Alkaloids-induced Liver Injury. [PDF]
J Clin Transl HepatolJi M +8 more
europepmc +1 more source
A case of thrombotic thrombocytopenic purpura induced by acute hepatitis E and successfully controlled by lymphoplasmapheresis plus rituximab. [PDF]
Virol JYu B, Zhu Y, Jin Z, Han F, Lv F.
europepmc +1 more source
Multicenter Prospective Pilot Study Identifying Thrombomodulin as a Potential Biomarker for Neurocognitive Outcomes in Immune Thrombotic Thrombocytopenic Purpura. [PDF]
J Clin MedBoothby AB +7 more
europepmc +1 more source
Comparison of the Novel Thrombolytic Constitutively Active ADAMTS13 With Clinical Thrombolytics in a Murine Stroke Model. [PDF]
StrokeRoberts L +5 more
europepmc +1 more source